Mangoceuticals, Inc.
General ticker "MGRX" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $10.7M (TTM average)
Mangoceuticals, Inc. does not follow the US Stock Market performance with the rate: -24.1%.
Estimated limits based on current volatility of 5.4%: low 0.41$, high 0.45$
Factors to consider:
- Total employees count: 750 as of 2023
- Current price 26.7% below estimated low
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.62$, 1.86$]
- 2026-12-31 to 2027-12-31 estimated range: [0.52$, 1.57$]
Financial Metrics affecting the MGRX estimates:
- Positive: with PPE of -0.3 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -69.63 <= 0.02
- Positive: Investing cash flow per share per price, % of 0 > -0.63
- Positive: Shareholder equity ratio, % of 94.47 > 64.15
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term MGRX quotes
Long-term MGRX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.73MM | $0.62MM | $0.46MM |
| Operating Expenses | $9.95MM | $8.59MM | $19.61MM |
| Operating Income | $-9.22MM | $-7.97MM | $-19.15MM |
| Non-Operating Income | $0.01MM | $-0.74MM | $-1.49MM |
| Interest Expense | $0.00MM | $0.01MM | $0.10MM |
| Income(Loss) | $-9.21MM | $-8.71MM | $-20.64MM |
| Profit(Loss)* | $-9.21MM | $-8.71MM | $-20.64MM |
| Stockholders Equity | $0.77MM | $13.95MM | $15.20MM |
| Inventory | $0.02MM | $0.00MM | $0.00MM |
| Assets | $1.05MM | $15.37MM | $16.09MM |
| Operating Cash Flow | $-7.00MM | $-4.86MM | $-5.85MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.00MM | $0.07MM | $0.00MM |
| Financing Cash Flow | $7.06MM | $4.13MM | $7.27MM |
| Earnings Per Share** | $-8.58 | $-4.40 | $-2.05 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.